Health Care & Life Sciences » Pharmaceuticals | China Medical System Holdings Ltd.

China Medical System Holdings Ltd.

China Medical System Holdings Ltd.
Stock Exchange Hong Kong Stock Exchange
EPS
HKD0.88
Market Cap
HKD18.63 B
Shares Outstanding
2.48 B
Public Float
1.32 B

Profile

Address
6/F-8/F, Block B
Shenzhen Guangdong 518052
China
Employees -
Website http://www.cms.net.cn
Updated 07/08/2019
China Medical System Holdings Ltd. engages in the provision of pharmaceutical products and services. The company focuses on the manufacture, marketing, promotion, and sale of drugs. Its products include Plendi, XinHuoSu, Stulln, XiDaKang, YiNuoShu, DanShenTong, Hirudoid, NuoDiKang, Combizym, GanFuLe, Imdur, Parlodel, Lamisil, YinLianQingGan, and MOVICOL.

Financials

View All
Created with Highcharts 5.0.14China Medical System Holdings Ltd.Net Income. Fiscal year is January-December. All values HKD Millions.7987981 3161 3161 2281 2281 6081 6081 9311 9312 1912 19120132014201520162017201805001000150020002500
Created with Highcharts 5.0.14China Medical System Holdings Ltd.Sales/Revenue. Fiscal year is January-December. All values HKD Millions.2 8182 8183 7073 7074 3834 3835 7265 7266 1686 1686 4366 43620132014201520162017201802k4k6k8k

Kong Lam
Chairman, President & Chief Executive Officer
Hong Bing Chen
Chief Operating Officer, Executive Director & VP